Building a Healthcare Business in Europe Panelists

  • Anthony Sun, Partner, Aisling Capital, Panel Moderator

    Dr. Sun joined Fund I in 2002 and currently serves as a Partner. Previously, Dr. Sun was an Adjunct Instructor of Medicine at the Hospital of the University of Pennsylvania. 

Dr. Sun currently serves as a director of CeNeRx BioPharma, Inc., Dynova Laboratories, Inc., HerbalScience, Inc., and Paratek Pharmaceuticals, Inc. Previously he served as a director of MAP Pharmaceuticals, Inc. 

Dr. Sun received his M.D. from Temple University School of Medicine with A.O.A. honors. He received his M.B.A. from The Wharton School at the University of Pennsylvania, and his B.S. in Electrical Engineering from Cornell University. In addition, he is Board Certified in Internal Medicine.

    Daniel Bertholet, Investment Director, Endeavour Vision

    Daniel Bertholet is an Investment Director in the Life Sciences practice at Endeavour Vision, with a focus on medtech investments. Daniel has invested in Symetis, CeQur, Endoart (sold to Allergan), Thommen Medical (exited), Kuros Biosurgery, Novalar Pharmaceuticals and Neocutis. He also participated in investments and/or follow-on investments in Native Networks, eProject/Daptiv, Paion, Nexx Systems and Novimmune. Prior to his venture capital career, Daniel was the co-founder and CFO of a technology start-up and has invested as a business angel/private investor in private companies for over 15 years in Europe and the US. Daniel started his career as a consultant in country risk assessment for Business Environment Risk Intelligence (BERI) in the US and Switzerland.

    Thom Rasche, Partner, Earlybird Venture Capital

    Thom Rasche joined Earlybird as a Venture Partner in 2003 and was promoted to Partner in 2006. He is a seasoned executive in the medical device and diagnostic sectors with over 20 years of operational experience.

Since he joined Earlybird, Thom has been responsible for the medical device portfolio and for making new investments in this area. He has successfully led various financing rounds in both European and US based medical device companies before the investment in Miracor.

Thom is on the board of Zonare Medical Systems and has held various senior marketing and sales positions with Johnson & Johnson in Europe and the US. Thom Rasche holds a Degree as Diplom Kaufmann (MBA equivalent) from the University of Applied Sciences in Lüneburg, Germany, specializing in marketing and human resource management.

    Carla Kikken-Jussen, President, CEO and Founder, MediTech Strategic Consultants B.V

    Carla Kikken-Jussen established MediTech over a decade ago. Her over 25 years of experience in the medical device industry covers medical device clinical research and European Regulatory Affairs. Since 2000, Carla has brought hundreds of client’s medical devices and combination products to market in the European Union and Israel, Norway, Switzerland and Turkey as well as obtaining European clinical data that is acceptable to the FDA. Carla’s industry experience includes her work with the Technical Committees and Working Groups of the European Commission in various areas: CEN-TC-316 “Animal tissues and their derivatives utilized in the manufacture of medical devices”; CEN-BT-WG 132 “Methods for analysis of Allergens” and NEN-301-007 “Quality Systems for Body Materials”. She served on the board of the Life Sciences Limburg Group and is a member of the Dutch Standardization Institute (NEN), the Regulatory Affairs Professional Society (RAPS) European Advisory Committee and the Orange County Regulatory Affairs organization. In 2008 Carla was the first female to be awarded the Entrepreneur of the Year by Rabobank Demarrage and in 2010 was awarded the Best Woman Entrepreneur by the Dutch Federation of Businesswomen.

    Back to Trans-Atlantic Conference Programming

  • Conference Info:


    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City

    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!